Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia
Listen to this summary
The authors investigate the potential of targeting the cannabinoid CB1 receptor (CB1R) as a therapeutic strategy for treating schizophrenia, particularly in individuals with comorbid cannabis use. They review the relationship between the endocannabinoid system and schizophrenia, highlighting how cannabis exacerbates symptoms and affects prognosis. The paper aims to outline recent advances in understanding CB1R biology and pharmacology that could inform the development of effective treatments for schizophrenia.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from The American journal of psychiatry
View all →May 6, 2026 · The American journal of psychiatry
Clinical and Cognitive Outcomes Comparing Right Unilateral Ultrabrief Electroconvulsive Therapy Versus Magnetic Seizure Therapy for Bipolar Depression: The CORRECT-BD Trial
Apr 22, 2026 · The American journal of psychiatry
Transcriptional Profiles of Somatostatin and Parvalbumin Interneuron Subtypes in the Human Dorsolateral Prefrontal Cortex: Implications for Schizophrenia
Apr 17, 2026 · The American journal of psychiatry
The Comparative Efficacy of Noninvasive Brain Stimulation for Suicidal Ideation: A Network Meta-Analysis
Apr 2, 2026 · The American journal of psychiatry
Regional Blood Flow Signatures of Opioidergic Modulation of Ketamine in Major Depressive Disorder: A Randomized Crossover Study
Apr 2, 2026 · The American journal of psychiatry
Personalized fMRI-Guided TMS Targeting the Threat Neurocircuitry in PTSD: A Randomized Clinical Trial
Apr 2, 2026 · The American journal of psychiatry
Resting-State Functional Connectivity of the Amygdala and Hippocampus in PTSD: Results From the PGC-ENIGMA PTSD Working Group
More in Psychiatry & Neurology
View all →May 11, 2026 · Journal of addiction medicine
Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-Analysis
May 11, 2026 · The British journal of psychiatry : the journal of mental science
Effectiveness and acceptability of different psychotherapies for obsessive-compulsive disorder: network meta-analysis
May 11, 2026 · Journal of addiction medicine
Prolonged Fentanyl Detection on Urine Drug Testing: A Case for Revising Interpretation Frameworks in the Setting of Chronic Use
May 11, 2026 · Journal of addiction medicine
Development and Testing of a Peer Recovery Support Services Intervention for Retention on Medications for Opioid Use Disorder
May 11, 2026 · Journal of addiction medicine
The Economic Impact of Medetomidine on Critical Care Utilization: A Longitudinal Analysis of Intensive Care Unit Charges for Opioid Withdrawal Across the Adulterated Era
May 8, 2026 · Journal of palliative medicine
"We Talk About Everything": Experiences with Digital Health Communication in Palliative Care
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


